Matthias Aizenberg

Recent breakthroughs are fundamentally recasting our understanding of cancer, shifting the focus from a disease of uncontrolled cell division to one characterized by a profoundly altered and ravenous metabolism. At the heart of this new perspective is the discovery that malignant cells harbor a

A new frontier in the fight against cancer is emerging from an unexpected source: the trillions of microorganisms residing within the human gut. For years, the medical community has grappled with a persistent challenge in oncology—the fact that powerful immunotherapy treatments, designed to unleash

A comprehensive large-scale study has uncovered a significant and concerning connection between long-term exposure to wildfire smoke and an elevated risk of stroke among older adults, reframing a seasonal environmental nuisance as a potent, year-round public health threat. Research led by experts

Today we’re joined by Ivan Kairatov, a biopharma expert with deep experience in drug development and the intricate dance between innovation, regulation, and market perception. We'll be dissecting the recent developments with Intellia Therapeutics, a pioneer in CRISPR gene editing. The company has

A faint tinge of pink swirling in the toilet bowl is an unmistakable alarm bell for most, signaling an urgent need for medical attention, but for millions, this critical warning sign of a potentially treatable cancer remains completely invisible. New research reveals a shocking reality: individuals

Today, we have the privilege of speaking with Dr. Ivan Kairatov, a leading biopharma expert whose research has illuminated the intricate connections between lipid genetics and liver health. We'll be exploring the often-overlooked condition of Familial Hypobetalipoproteinemia, or FHBL, and how this

The intricate molecular machinery that underpins all life has become a canvas for artificial intelligence, leading to a new era where biological catalysts can be designed from the ground up for specific human needs. A collaborative team from Graz University of Technology and the University of Graz

The same biological process that heroically defends the body against injury and infection can become a relentless saboteur when it fails to disengage, driving many of modern medicine's most formidable chronic diseases. For decades, the focus of anti-inflammatory treatment has been on suppressing

The arduous journey of a new drug from a laboratory concept to a patient's hands is a monumental undertaking, an odyssey fraught with staggering costs, extensive research, and an alarmingly high probability of failure. For every ten promising drug candidates that enter the rigorous phase of human

Artificial intelligence has made remarkable strides in recognizing human emotions from facial expressions and tone of voice, but a groundbreaking new framework is now aiming for a far more ambitious goal: computationally modeling how emotions are formed in the first place. Researchers in Japan have